603122 合富中国
已收盘 03-27 15:00:00
资讯
新帖
简况
合富中国(603122)2月28日股东户数7.5万户，较上期减少31.84%
证券之星 · 03-14
合富中国(603122)2月28日股东户数7.5万户，较上期减少31.84%
图解合富中国年报：第四季度单季净利润同比下降2195.50%
证券之星 · 03-14
图解合富中国年报：第四季度单季净利润同比下降2195.50%
合富中国最新公告：2025年净亏损3364.3万元不进行利润分配
证券之星 · 03-13
合富中国最新公告：2025年净亏损3364.3万元不进行利润分配
合富中国：2026年1月-2月累计营业收入简报
证券日报 · 03-10
合富中国：2026年1月-2月累计营业收入简报
合富中国(603122.SH)1-2月累计合并营收9832.09万元 同比减少10.34%
智通财经 · 03-10
合富中国(603122.SH)1-2月累计合并营收9832.09万元 同比减少10.34%
合富中国最新公告：累计诉讼涉案金额1.42亿元
证券之星 · 03-01
合富中国最新公告：累计诉讼涉案金额1.42亿元
合富中国(603122.SH)1月合并营业收入同比减少10.24%
智通财经 · 02-10
合富中国(603122.SH)1月合并营业收入同比减少10.24%
每周股票复盘：合富中国（603122）因股价跌幅偏离上榜龙虎榜
证券之星 · 02-08
每周股票复盘：合富中国（603122）因股价跌幅偏离上榜龙虎榜
2月6日合富中国（603122）龙虎榜数据
证券之星 · 02-06
2月6日合富中国（603122）龙虎榜数据
异动快报：合富中国（603122）2月6日9点42分触及跌停板
证券之星 · 02-06
异动快报：合富中国（603122）2月6日9点42分触及跌停板
合富中国（603122）披露关于回复上海证券交易所监管工作函的公告，2月04日股价上涨0.49%
证券之星 · 02-04
合富中国（603122）披露关于回复上海证券交易所监管工作函的公告，2月04日股价上涨0.49%
每周股票复盘：合富中国（603122）2025年预亏3600万至2500万元
证券之星 · 02-01
每周股票复盘：合富中国（603122）2025年预亏3600万至2500万元
合富中国（603122）披露证券事务代表离职公告，1月30日股价下跌0.11%
证券之星 · 01-30
合富中国（603122）披露证券事务代表离职公告，1月30日股价下跌0.11%
上市满月即签6亿合约：明基医院与合富中国的双向妥协与隐忧
观察者网 · 01-27
上市满月即签6亿合约：明基医院与合富中国的双向妥协与隐忧
合富中国最新公告：与明基医院签订采购总金额不低于6亿元的长期采购协议
证券之星 · 01-25
合富中国最新公告：与明基医院签订采购总金额不低于6亿元的长期采购协议
合富中国最新公告：预计2025年净亏损2500万元-3600万元
证券之星 · 01-25
合富中国最新公告：预计2025年净亏损2500万元-3600万元
合富中国与明基医院签订八年期供货协议 最低金额达6亿元
美股速递 · 01-25
合富中国与明基医院签订八年期供货协议 最低金额达6亿元
股市必读：合富中国（603122）今年截至1月21日累计跌幅已超25%
证券之星 · 01-22
股市必读：合富中国（603122）今年截至1月21日累计跌幅已超25%
每周股票复盘：合富中国（603122）周内跌停登龙虎榜
证券之星 · 01-18
每周股票复盘：合富中国（603122）周内跌停登龙虎榜
异动快报：合富中国（603122）1月15日14点10分触及跌停板
证券之星 · 01-15
异动快报：合富中国（603122）1月15日14点10分触及跌停板
加载更多
公司概况
公司名称：
合富(中国)医疗科技股份有限公司
所属行业：
批发业
上市日期：
2022-02-16
主营业务：
合富(中国)医疗科技股份有限公司的主营业务是以体外诊断相关的医疗设备及其耗材为主的国际贸易、售后服务，贸易代理，医院信息管理系统的咨询服务以及相关配套服务。公司的主要产品是体外诊断产品集约化业务、医疗产品流通。
发行价格：
4.19
{"stockData":{"symbol":"603122","market":"SH","secType":"STK","nameCN":"合富中国","latestPrice":15.38,"timestamp":1774594801000,"preClose":15.17,"halted":0,"volume":11640700,"delay":0,"changeRate":0.0138,"floatShares":398000000,"shares":398000000,"eps":-0.2383,"marketStatus":"已收盘","change":0.21,"latestTime":"03-27 15:00:00","open":15.02,"high":15.46,"low":14.96,"amount":178000000,"amplitude":0.033,"askPrice":15.38,"askSize":1394,"bidPrice":15.37,"bidSize":197,"shortable":0,"etf":0,"ttmEps":-0.2383,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774834200000},"marketStatusCode":5,"adr":0,"adjPreClose":15.17,"symbolType":"stock","openAndCloseTimeList":[[1774575000000,1774582200000],[1774587600000,1774594800000]],"highLimit":16.69,"lowLimit":13.65,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":398052633,"isCdr":false,"pbRate":5.79,"roa":"--","roe":"--","epsLYR":-0.08,"committee":0.373196,"marketValue":6122000000,"turnoverRate":0.0292,"status":0,"floatMarketCap":6122000000},"requestUrl":"/m/hq/s/603122","defaultTab":"news","newsList":[{"id":"2619812584","title":"合富中国(603122)2月28日股东户数7.5万户，较上期减少31.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619812584","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619812584?lang=zh_cn&edition=full","pubTime":"2026-03-14 17:02","pubTimestamp":1773478962,"startTime":"0","endTime":"0","summary":"证券之星消息，近日合富中国披露，截至2026年2月28日公司股东户数为7.5万户，较12月31日减少3.5万户，减幅为31.84%。在医药商业行业个股中，合富中国股东户数高于行业平均水平，截至2月28日，医药商业行业平均股东户数为4.26万户。从股价来看，2025年12月31日至2026年2月28日，合富中国区间跌幅为29.8%，在此期间股东户数减少3.5万户，减幅为31.84%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031400013276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","603122"],"gpt_icon":0},{"id":"2619399114","title":"图解合富中国年报：第四季度单季净利润同比下降2195.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619399114","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619399114?lang=zh_cn&edition=full","pubTime":"2026-03-14 01:13","pubTimestamp":1773422006,"startTime":"0","endTime":"0","summary":"证券之星消息，合富中国2025年年报显示，当年度公司主营收入6.78亿元，同比下降27.83%；归母净利润-3364.3万元，同比下降222.04%；扣非净利润-3326.5万元，同比下降227.4%；其中2025年第四季度，公司单季度主营收入1.29亿元，同比下降43.49%；单季度归母净利润-2125.68万元，同比下降2195.5%；单季度扣非净利润-2152.5万元，同比下降596.63%；负债率25.82%，投资收益-21.49万元，财务费用-166.42万元，毛利率14.76%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031400000958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603122"],"gpt_icon":0},{"id":"2619116962","title":"合富中国最新公告：2025年净亏损3364.3万元不进行利润分配","url":"https://stock-news.laohu8.com/highlight/detail?id=2619116962","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619116962?lang=zh_cn&edition=full","pubTime":"2026-03-13 23:09","pubTimestamp":1773414573,"startTime":"0","endTime":"0","summary":"合富中国(603122.SH)公告称，2025年营业收入6.78亿元，同比下降27.83%。归属于上市公司股东的净亏损3364.3万元，上年同期净利润2756.63万元。公司2025年度不进行利润分配，也不进行资本公积金转增股本。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300042222.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","603122"],"gpt_icon":0},{"id":"2618955057","title":"合富中国：2026年1月-2月累计营业收入简报","url":"https://stock-news.laohu8.com/highlight/detail?id=2618955057","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618955057?lang=zh_cn&edition=full","pubTime":"2026-03-10 21:11","pubTimestamp":1773148260,"startTime":"0","endTime":"0","summary":"证券日报网讯 3月10日，合富中国发布公告称，2026年2月存在春节法定假期，公司2026年1月-2月累计合并营业收入为人民币9，832.09万元，较去年同期的合并营业收入减少10.34%。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-10/doc-inhqphnp6197497.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-10/doc-inhqphnp6197497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603122"],"gpt_icon":0},{"id":"2618935010","title":"合富中国(603122.SH)1-2月累计合并营收9832.09万元 同比减少10.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618935010","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618935010?lang=zh_cn&edition=full","pubTime":"2026-03-10 17:36","pubTimestamp":1773135411,"startTime":"0","endTime":"0","summary":"智通财经APP讯，合富中国(603122.SH)发布公告，公司2026年1-2月累计合并营业收入为人民币9832.09万元，较去年同期的合并营业收入减少10.34%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412183.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603122"],"gpt_icon":0},{"id":"2616246288","title":"合富中国最新公告：累计诉讼涉案金额1.42亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616246288","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616246288?lang=zh_cn&edition=full","pubTime":"2026-03-01 19:20","pubTimestamp":1772364018,"startTime":"0","endTime":"0","summary":"合富中国(603122.SH)公告称，公司及子公司、分公司连续十二个月累计发生诉讼案件合计金额为1.42亿元，占公司最近一期经审计净资产的12.08%。其中，作为原告的案件维权求偿金额合计为1.03亿元，作为被告的案件被要求赔偿金额合计为3879.90万元。主要诉讼案件包括与广东省第二人民医院的试剂买卖合同纠纷和放疗设备买卖合同纠纷。由于部分诉讼案件尚未开庭审理或作出生效判决，目前无法判断对公司本期利润或期后利润的影响。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100008518.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603122","BK0250"],"gpt_icon":0},{"id":"2610413236","title":"合富中国(603122.SH)1月合并营业收入同比减少10.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610413236","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610413236?lang=zh_cn&edition=full","pubTime":"2026-02-10 19:17","pubTimestamp":1770722255,"startTime":"0","endTime":"0","summary":"智通财经APP讯，合富中国(603122.SH)发布公告，公司2026年1月合并营业收入为人民币5302.10万元，较去年同期的合并营业收入减少10.24%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403797.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603122"],"gpt_icon":0},{"id":"2609231875","title":"每周股票复盘：合富中国（603122）因股价跌幅偏离上榜龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2609231875","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609231875?lang=zh_cn&edition=full","pubTime":"2026-02-08 01:09","pubTimestamp":1770484149,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘，合富中国报收于17.72元，较上周的17.78元下跌0.34%。本周，合富中国2月5日盘中最高价报19.78元。合富中国当前最新总市值70.53亿元，在医药商业板块市值排名18/32，在两市A股市值排名2701/5186。本周关注点来自交易信息汇总：合富中国因日收盘价格跌幅偏离值达到7%登上龙虎榜。来自公司公告汇总：合富中国回复监管函，称与明基医院签署6亿元最低采购额协议具备商业合理性。此次是近5个交易日内第1次上榜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800000069.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603122","BK0250"],"gpt_icon":0},{"id":"2609569344","title":"2月6日合富中国（603122）龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2609569344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609569344?lang=zh_cn&edition=full","pubTime":"2026-02-06 17:25","pubTimestamp":1770369949,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年2月6日公布的交易公开信息显示，合富中国因有价格涨跌幅限制的日收盘价格跌幅偏离值达到7%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年2月6日收盘，合富中国报收于17.72元，下跌10.01%，跌停，换手率14.9%，成交量59.31万手，成交额10.64亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600029092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","603122"],"gpt_icon":0},{"id":"2609532074","title":"异动快报：合富中国（603122）2月6日9点42分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2609532074","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609532074?lang=zh_cn&edition=full","pubTime":"2026-02-06 09:45","pubTimestamp":1770342324,"startTime":"0","endTime":"0","summary":"证券之星2月6日盘中消息，9点42分合富中国触及跌停板。其所属行业医药商业目前上涨。领涨股为人民同泰。该股为医药，医药商业，医疗耗材供应链SPD概念热股，当日医药概念上涨0.62%，医药商业概念上涨0.25%，医疗耗材供应链SPD概念上涨0.16%。2月5日的资金流向数据方面，主力资金净流入1.09亿元，占总成交额8.03%，游资资金净流入4413.04万元，占总成交额3.26%，散户资金净流出1.53亿元，占总成交额11.29%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600009712.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","603122"],"gpt_icon":0},{"id":"2608280354","title":"合富中国（603122）披露关于回复上海证券交易所监管工作函的公告，2月04日股价上涨0.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608280354","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608280354?lang=zh_cn&edition=full","pubTime":"2026-02-04 17:31","pubTimestamp":1770197489,"startTime":"0","endTime":"0","summary":"截至2026年2月4日收盘，合富中国报收于18.45元，较前一交易日上涨0.49%，最新总市值为73.44亿元。该股当日开盘18.34元，最高18.78元，最低18.21元，成交额达3.46亿元，换手率为4.71%。公司于近日披露《关于回复上海证券交易所监管工作函的公告》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400029770.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","603122"],"gpt_icon":0},{"id":"2608072027","title":"每周股票复盘：合富中国（603122）2025年预亏3600万至2500万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608072027","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608072027?lang=zh_cn&edition=full","pubTime":"2026-02-01 02:06","pubTimestamp":1769882774,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，合富中国报收于17.78元，较上周的18.98元下跌6.32%。本周，合富中国1月28日盘中最高价报19.07元。公司公告汇总合富（中国）医疗科技股份有限公司预计2025年年度归属于母公司所有者的净利润为-3,600万元到-2,500万元，与上年同期相比将出现亏损。合富（中国）医疗科技股份有限公司董事会于近日收到证券事务代表徐佳圆女士递交的书面辞职报告。截至公告日，徐佳圆女士未持有公司股份，亦无未履行承诺事项，工作已交接完毕。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100000532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603122","BK0250"],"gpt_icon":0},{"id":"2607355041","title":"合富中国（603122）披露证券事务代表离职公告，1月30日股价下跌0.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607355041","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607355041?lang=zh_cn&edition=full","pubTime":"2026-01-30 22:27","pubTimestamp":1769783236,"startTime":"0","endTime":"0","summary":"公告显示，公司董事会于近日收到证券事务代表徐佳圆女士递交的书面辞职报告。徐佳圆女士因个人职业规划原因申请辞去证券事务代表及法务专员职务，辞职后不再担任公司任何职务，辞职报告自送达董事会之日起生效。截至公告日，徐佳圆女士未持有公司股份，亦无未履行承诺事项，工作已交接完毕。公司董事会将依据相关规定尽快聘任新的证券事务代表。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000047336.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603122","161027","BK0250"],"gpt_icon":0},{"id":"2606208922","title":"上市满月即签6亿合约：明基医院与合富中国的双向妥协与隐忧","url":"https://stock-news.laohu8.com/highlight/detail?id=2606208922","media":"观察者网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606208922?lang=zh_cn&edition=full","pubTime":"2026-01-27 14:37","pubTimestamp":1769495820,"startTime":"0","endTime":"0","summary":"1月25日，距明基医院（02581.HK）登陆港交所仅满月之际，一则6亿元的长期采购合约意外刷屏医疗圈。同日，作为明基医院上市基石投资者之一的合富中国（603122.SH），同步披露2025年业绩预亏 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/20260127/c674335097.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0250","603122"],"gpt_icon":0},{"id":"2606202251","title":"合富中国最新公告：与明基医院签订采购总金额不低于6亿元的长期采购协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2606202251","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606202251?lang=zh_cn&edition=full","pubTime":"2026-01-25 17:01","pubTimestamp":1769331665,"startTime":"0","endTime":"0","summary":"合富中国(603122.SH)公告称，与南京明基医院、苏州明基医院签订《长期采购协议》，明基医院在96个月内采购总金额不低于6亿元。该合同为公司日常经营性合同，预计对公司2026年及后续年度业绩产生积极影响。但合同履约时间较长，存在因宏观政策、市场环境等不可预计因素影响导致合同无法如期或全面履行的风险。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500005902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","02581","603122"],"gpt_icon":0},{"id":"2606251206","title":"合富中国最新公告：预计2025年净亏损2500万元-3600万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606251206","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606251206?lang=zh_cn&edition=full","pubTime":"2026-01-25 17:00","pubTimestamp":1769331607,"startTime":"0","endTime":"0","summary":"合富中国(603122.SH)发布2025年年度业绩预告，预计归属于上市公司股东的净利润为-3600万元到-2500万元，与上年同期相比将出现亏损。业绩变动原因：受集采政策影响，客户采购价格下降、订单波动，叠加人员优化与能力升级投入及研发投入增加。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500005904.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","603122"],"gpt_icon":0},{"id":"1172190352","title":"合富中国与明基医院签订八年期供货协议 最低金额达6亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1172190352","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172190352?lang=zh_cn&edition=full","pubTime":"2026-01-25 16:52","pubTimestamp":1769331134,"startTime":"0","endTime":"0","summary":"合富中国近日宣布，已与明基医院集团签署一项长期供货协议。该合同有效期为八年，总价值不低于6亿元人民币。\n根据协议条款，合富中国将成为明基医院集团在医疗器械及耗材领域的核心供应商。此次合作将显著提升合富中国在医疗流通领域的市场占有率，并对公司未来经营业绩产生积极影响。\n此次战略合作的达成，标志着双方在医疗供应链协同发展方面取得重要突破。长期稳定的供货关系不仅有助于优化采购成本，也将为医疗服务质量提升提供有力支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["603122","BK0250"],"gpt_icon":0},{"id":"2605481750","title":"股市必读：合富中国（603122）今年截至1月21日累计跌幅已超25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605481750","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605481750?lang=zh_cn&edition=full","pubTime":"2026-01-22 00:56","pubTimestamp":1769014570,"startTime":"0","endTime":"0","summary":"截至2026年1月21日收盘，合富中国报收于17.77元，下跌2.31%，换手率5.4%，成交量21.5万手，成交额3.83亿元。当日关注点来自交易信息汇总：合富中国股价连续2日下跌，当日主力资金净流出3885.97万元，散户资金净流入6328.09万元。来自交易信息汇总：合富中国当日收盘报17.77元，跌2.31%，年初至今累计跌幅达26.66%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200000393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603122","BK0250"],"gpt_icon":0},{"id":"2604282929","title":"每周股票复盘：合富中国（603122）周内跌停登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2604282929","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604282929?lang=zh_cn&edition=full","pubTime":"2026-01-18 01:46","pubTimestamp":1768671972,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，合富中国报收于18.28元，较上周的21.71元下跌15.8%。本周，合富中国1月13日盘中最高价报23.94元。本周关注点来自交易信息汇总：合富中国因股价跌幅偏离值达7%登上龙虎榜。来自公司公告汇总：合富中国2025年全年营收同比下降26.67%至6.89亿元。交易信息汇总龙虎榜上榜沪深交易所2026年1月14日公布的交易公开信息显示，合富中国因有价格涨跌幅限制的日收盘价格跌幅偏离值达到7%的前五只证券登上龙虎榜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800000307.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","603122"],"gpt_icon":0},{"id":"2603367597","title":"异动快报：合富中国（603122）1月15日14点10分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2603367597","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603367597?lang=zh_cn&edition=full","pubTime":"2026-01-15 14:10","pubTimestamp":1768457442,"startTime":"0","endTime":"0","summary":"证券之星1月15日盘中消息，14点10分合富中国（603122）触及跌停板。其所属行业医药商业目前下跌。领涨股为润达医疗。该股为自贸区，医药，医疗器械概念热股。1月14日的资金流向数据方面，主力资金净流出2.31亿元，占总成交额14.44%，游资资金净流入1671.33万元，占总成交额1.04%，散户资金净流入2.15亿元，占总成交额13.4%。近5日资金流向一览见下表：合富中国主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500019033.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603122","BK0250"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774652209248,"stockEarnings":[{"period":"1week","weight":-0.0109},{"period":"1month","weight":-0.0948},{"period":"3month","weight":-0.3964},{"period":"6month","weight":1.3919},{"period":"1year","weight":1.2041},{"period":"ytd","weight":-0.3697}],"compareEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":-0.0563},{"period":"3month","weight":-0.0126},{"period":"6month","weight":0.0224},{"period":"1year","weight":0.1601},{"period":"ytd","weight":-0.0139}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"合富(中国)医疗科技股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"75003人(较上一季度减少31.84%)","perCapita":"5307股","listingDate":"2022-02-16","address":"上海市浦东新区中国(上海)自由贸易试验区新灵路118号606B室","registeredCapital":"39805万元","survey":" 合富(中国)医疗科技股份有限公司的主营业务是以体外诊断相关的医疗设备及其耗材为主的国际贸易、售后服务，贸易代理，医院信息管理系统的咨询服务以及相关配套服务。公司的主要产品是体外诊断产品集约化业务、医疗产品流通。","listedPrice":4.19},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"合富中国(603122)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供合富中国(603122)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"合富中国,603122,合富中国股票,合富中国股票老虎,合富中国股票老虎国际,合富中国行情,合富中国股票行情,合富中国股价,合富中国股市,合富中国股票价格,合富中国股票交易,合富中国股票购买,合富中国股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"合富中国(603122)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供合富中国(603122)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}